|
|
|
|
Evolution of renal function during treatment with direct antiviral agents (DAA-t) in HIV/HCV infected patients in ICONA/HepaIcona cohorts
|
|
|
Reported by Jules Levin
EACS - 16th European AIDS Conference, October 25-27, 2017. Milan
Antonella Cingolani1, Laura Galli2, Giuseppe Lapadula3, Stefano Bonora4, Caterina Uberti Foppa2, Antonio Di Biagio5, Gabriella Verucchi6, Silvia Odolini7, Cristina Mussini8, Andrea Antinori9, Antonella d'Arminio Monforte10, Mauro Zaccarelli8
for Icona Foundation Study Group
1 Institute of Clinical Infectious Diseases, Catholic University of Sacred Heart, Policlinico Gemelli, Rome, Italy;
2 Department of Infectious Diseases, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy;
3 Division of Infectious Diseases, ASST Monza-Brianza- San Gerardo Hospital, Monza, Italy.
4 Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Amedeo di Savoia Hospital,
5 Unit of Infectious Diseases, IRCCS San Martino Hospital-IST, Genoa, Italy.
6 Unit of Infectious Diseases, S.Orsola-Malpighi Hospital, "Alma Mater Studiorum" University of Bologna,Bologna, Italy;
7 University Department of Infectious and Tropical Diseases, Spedali Civili General Hospital, Brescia, Italy
8 Infectious Disease Clinic, Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, Modena, Italy.
9 HIV/AIDS Department, INMI "L. Spallanzani" IRCCS, Rome, Italy;
10 ASST Santi Paolo e Carlo, University of Milan, Clinic of Infectious and Tropical Diseases, Department of Health Sciences, Milan, Italy.
Diabetes & TDF......
|
|
|
|
|
|
|